The DOI matches its Crossref record; 75 of the 78 references it cites were found in a registry or an index.
Synaptic Activity Reduces Intraneuronal Aβ, Promotes APP Transport to Synapses, and Protects against Aβ-Related Synaptic Alterations
Open accessAbstract
A central question in Alzheimer's disease research is what role synaptic activity plays in the disease process. Synaptic activity has been shown to induce β-amyloid peptide release into the extracellular space, and extracellular β-amyloid has been shown to be toxic to synapses. We now provide evidence that the well established synaptotoxicity of extracellular β-amyloid requires γ-secretase processing of amyloid precursor protein. Recent evidence supports an important role for intraneuronal β-amyloid in the pathogenesis of Alzheimer's disease. We show that synaptic activity reduces intraneuronal β-amyloid and protects against β-amyloid-related synaptic alterations. We demonstrate that synaptic activity promotes the transport of the amyloid precursor protein to synapses using live cell imaging, and that the protease neprilysin is involved in reduction of intraneuronal β-amyloid with synaptic activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recently, additional evidence pointed to the importance of amyloidogenic processing of APP, and therefore potentially intraneuronal Aβ, in extracellular Aβ-induced synapse dysfunction [190].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [190]
In the citing paper
“In fact synaptic activity was recently shown to promote APP transport down neurites to synapses [190].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [190]
In the citing paper
“Moreover, synaptic activity was recently shown to reduce the intraneuronal pool of Aβ in vitro and in vivo [190].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [190]
In the citing paper
“A recent neurobiological study showed that it was reduction of intraneuronal rather than extracellular Aβ that correlated with synaptic improvement [190].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [190]
In the citing paper
“Work in the 1990s had shown that extracellular Aβ1-42 led to marked up-regulation of endogenously generated Aβ42 [51, 211], which also occurs in neurons [190].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [190]
In the citing paper
“The protease shown to most efficiently degrade Aβ, neprilysin [81], was reported to be critical in synaptic activity-induced intraneuronal Aβ42 reduction [190].”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Palop, J. J., Chin, J., Roberson, E. D., Wang, J., Thwin, M. T., Bien-Ly, N., Yoo, J., Ho, K. O., Yu, G.-Q., Kreitzer, A., et al. (2007) · Neuron · doi:10.1016/j.neuron.2007.07.025 · Cited by 1,653
APP Processing and Synaptic Function
Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644
Research works printed but not linked: 1
- 10.1097/00002093-200607001-00010 · DOI · Paper page
Cited by
Sorted by citations
Protein aggregation diseases: pathogenicity and therapeutic perspectives
Aguzzi, A., & O’Connor, T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3050 · Cited by 766
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S.-I., Dziewczapolski, G., Nakamura, T., Cao, G., Pratt, A. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306832110 · Cited by 600
Kapogiannis, D., & Mattson, M. P. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70277-5 · Cited by 594
Kent, S. A., Spires-Jones, T. L., & Durrant, C. S. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02196-w · Cited by 446
Probing the biology of Alzheimer’s disease in mice
Ashe, K. H., & Zahs, K. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.04.031 · Cited by 413
The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
Lackie, R. E., Maciejewski, A., Ostapchenko, V. G., Marques-Lopes, J., Choy, W., Duennwald, M. L., Prado, V. F., & Prado, M. A. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00254 · Cited by 390
Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease
Gouras, G. K., Tampellini, D., Takahashi, R. H., & Capetillo-Zarate, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0679-9 · Cited by 372
Self-citationβ-amyloid Peptides and Amyloid Plaques in Alzheimer's Disease
Gouras, G. K., Olsson, T. T., & Hansson, O. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0313-y · Cited by 346
Self-citationThe Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
Brothers, H. M., Gosztyla, M. L., & Robinson, S. R. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00118 · Cited by 314
Role of Amyloid-β and Tau Proteins in Alzheimer’s Disease: Confuting the Amyloid Cascade
Gulisano, W., Maugeri, D., Baltrons, M. A., Fà, M., Amato, A., Palmeri, A., D’Adamio, L., Grassi, C., Devanand, D. P., Honig, L. S., et al. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179935 · Cited by 313
Ma, T., Hoeffer, C. A., Capetillo-Zarate, E., Yu, F., Wong, H., Lin, M. T., Tampellini, D., Klann, E., Blitzer, R. D., & Gouras, G. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012845 · Cited by 262
Self-citationGinsberg, S. D., Alldred, M. J., Counts, S. E., Cataldo, A. M., Neve, R. L., Jiang, Y., Wuu, J., Chao, M. V., Mufson, E. J., Nixon, R. A., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.030 · Cited by 243
Reddy, P. H., Mańczak, M., Mao, P., Calkins, M. J., Reddy, A. P., & Shirendeb, U. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100504 · Cited by 247
Ricobaraza, A., Cuadrado‐Tejedor, M., Marco, S., Pérez‐Otaño, I., & García‐Osta, A. (2012) · Hippocampus · doi:10.1002/hipo.20883 · Cited by 239
Analyzing dendritic spine pathology in Alzheimer’s disease: Problems and opportunities
Dorostkar, M. M., Zou, C., Blazquez-Llorca, L., & Herms, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1449-5 · Cited by 235
Naert, G., & Rivest, S. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0299-11.2011 · Cited by 207
“Moreover, synaptic activity can reduce intraneuronal A by Mme action and protect against A -related synaptic alterations (Tampellini et al., 2009).”
BackgroundNeuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer’s disease
Baker‐Nigh, A., Vahedi, S., Davis, E., Weıntraub, S., Bigio, E. H., Klein, W. L., & Geula, C. (2015) · Brain · doi:10.1093/brain/awv024 · Cited by 211
Imbimbo, B. P., & Giardina, G. A. M. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795860942 · Cited by 196
Protein aggregate spreading in neurodegenerative diseases: Problems and perspectives
Lee, S., Lim, H.-S., Masliah, E., & Lee, H.-J. (2011) · Neuroscience Research · doi:10.1016/j.neures.2011.05.008 · Cited by 190
Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid
Ubelmann, F., Burrinha, T., Salavessa, L., Gomes, R., Ferreira, C., Moreno, N., & Guimas Almeida, C. (2017) · The EMBO Reports · doi:10.15252/embr.201642738 · Cited by 165
Tampellini, D., Capetillo‐Zarate, E., Dumont, M., Huang, Z., Yu, F., Lin, M. T. S., & Gouras, G. K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3383-10.2010 · Cited by 165
Self-citationDumont, M., Kipiani, K., Yu, F., Wille, E. J., Katz, M., Calingasan, N. Y., Gouras, G. K., Lin, M. T. S., & Beal, M. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110209 · Cited by 164
Self-citationChronic Intermittent Hypoxia/Reoxygenation Facilitate Amyloid-β Generation in Mice
Shiota, S., Takekawa, H., Matsumoto, S., Takeda, K., Nurwidya, F., Yoshioka, Y., Takahashi, F., Hattori, N., Tabira, T., Mochizuki, H., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130419 · Cited by 155
More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration
Lane-Donovan, C., Philips, G. T., & Herz, J. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.005 · Cited by 158
Days to criterion as an indicator of toxicity associated with human Alzheimer amyloid‐β oligomers
Gandy, S., Simon, A. J., Steele, J., Lublin, A. L., Lah, J. J., Walker, L. C., Levey, A. I., Krafft, G. A., Levy, E., Checler, F., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22052 · Cited by 140
Marchetti, C., & Marie, H. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.035 · Cited by 141
Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau
Van der Jeugd, A., Hochgräfe, K., Ahmed, T., Decker, J. M., Sydow, A., Hofmann, A., Wu, D., Messing, L., Balschun, D., D’Hooge, R., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0987-3 · Cited by 135
Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer’s disease
Ma, T., & Klann, E. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07506.x · Cited by 140
Self-citationEndocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer’s disease
Marcello, E. E., Saraceno, C., Musardo, S., Vara, H., de la Fuente, A. G., Pelucchi, S., Marino, D. D., Borroni, B., Tramontano, A. L., Pérez‐Otaño, I., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65401 · Cited by 120
Kawahara, K., Suenobu, M., Yoshida, A., Koga, K., Hyodo, A., Ohtsuka, H., Kuniyasu, A., Tamamaki, N., Sugimoto, Y., & Nakayama, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.01.049 · Cited by 113
Stargardt, A., Swaab, D. F., & Bossers, K. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.08.014 · Cited by 109
Synaptic activity and Alzheimer's disease: a critical update
Tampellini, D. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00423 · Cited by 110
Self-citationGlutamate receptors in preclinical research on Alzheimer's disease: Update on recent advances
Hu, N., Ondrejčák, T., & Rowan, M. J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.013 · Cited by 99
The Pharmacological Properties and Therapeutic Use of Apomorphine
Ribarič, S. (2012) · Molecules · doi:10.3390/molecules17055289 · Cited by 101
Therapeutic intervention for Alzheimer's disease with γ-secretase inhibitors: still a viable option?
Imbimbo, B. P., Panza, F., Frisardi, V., Solfrizzi, V., D’Onofrio, G., Logroscino, G., Seripa, D., & Pilotto, A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.550572 · Cited by 99
Murmu, R. P., Li, W., Holtmaat, A., & Li, J.-Y. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.5284-12.2013 · Cited by 95
Pre-plaque conformational changes in Alzheimer’s disease-linked Aβ and APP
Klementieva, O. L., Willén, K. I., Martinsson, I., Israelsson, B., Engdahl, A., Cladera, J., Uvdal, P., & Gouras, G. K. (2017) · Nature Communications · doi:10.1038/ncomms14726 · Cited by 98
Self-citationAβ Internalization by Neurons and Glia
Mohamed, A., & Chaves, E. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/127984 · Cited by 94
Is Brain Amyloid Production a Cause or a Result of Dementia of The Alzheimer's Type?
Struble, R. G., Ala, T., Patrylo, P. R., Brewer, G. J., & Yan, X. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100846 · Cited by 85
Cai, W., Li, L., Sang, S., Pan, X., & Zhong, C. (2023) · Neuroscience Bulletin · doi:10.1007/s12264-022-00985-9 · Cited by 83
Mann, A., Gondard, E., Tampellini, D., MILSTED, J. A. T., Marillac, D., Hamani, C., Kalia, S. K., & Lozano, A. M. (2017) · Brain stimulation · doi:10.1016/j.brs.2017.11.012 · Cited by 92
Self-citationNew therapeutic targets in Alzheimer's disease: brain deregulation of calcium and zinc
Corona, C., Pensalfini, A., Frazzini, V., & Sensi, S. L. (2011) · Cell Death and Disease · doi:10.1038/cddis.2011.57 · Cited by 81
Bharadwaj, P. R., Bates, K. A., Porter, T., Teimouri, E., Perry, G. L., Steele, J., Gandy, S., Groth, D., Martins, R. N., & Verdile, G. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.97 · Cited by 81
The influence of synaptic activity on neuronal health
Bell, K. F., & Hardingham, G. E. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.01.002 · Cited by 77
Bhattacharyya, R., Black, S. E., Lotlikar, M. S., Fenn, R. H., Jorfi, M., Kovacs, D. M., & Tanzi, R. E. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109134 · Cited by 77
Synapses, NMDA receptor activity and neuronal Aβ production in Alzheimer’s disease
Bordji, K., Becerril-Ortega, J., & Buisson, A. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.029 · Cited by 75
Wan, X.-Z., Li, B., Li, Y.-C., Yang, X., Zhang, W., Zhong, L., & Tang, S.-J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3916-11.2012 · Cited by 66
Koppensteiner, P., Trinchese, F., Fà, M., Puzzo, D., Gulisano, W., Yan, S., Poussin, A., Liu, S., Orozco, I. J., Dale, E., et al. (2016) · Scientific Reports · doi:10.1038/srep32553 · Cited by 67
Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
Perdigão, C., Barata, M. A., Araújo, M. N. C. D. F., Mirfakhar, F. S., Castanheira, J., & Almeida, C. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00072 · Cited by 66
Synaptic activity protects against AD and FTD-like pathology via autophagic-lysosomal degradation
Akwa, Y., Gondard, E., Mann, A., Capetillo‐Zarate, E., Alberdi, E. M., Matute, C., Marty, S., Vaccari, T., Lozano, A. M., Baulieu, E. E., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.142 · Cited by 62
Self-citationWang, H., Megill, A., He, K., Kirkwood, A., & Lee, H. (2012) · Neural Plasticity · doi:10.1155/2012/272374 · Cited by 66
Petrov, A. M., Kasimov, M. R., & Zefirov, A. L. (2017) · Acta Naturae · doi:10.32607/20758251-2017-9-1-26-37 · Cited by 56
Enhanced -secretase processing alters APP axonal transport and leads to axonal defects
Rodrigues, E. M., Weissmiller, A. M., & Goldstein, L. S. B. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds297 · Cited by 56
Synapses, synaptic activity and intraneuronal Aβ in Alzheimer’s disease
Tampellini, D. (2010) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2010.00013 · Cited by 58
Self-citationDevelopmental neuroplasticity and the origin of neurodegenerative diseases
Schaefers, A. T. U., & Teuchert, G. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.797104 · Cited by 57
Durrant, C. S., & Coleman, M. P. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0110-7 · Cited by 55
Niederst, E. D., Reyna, S. M., & Goldstein, L. S. B. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-06-1049 · Cited by 51
Yang, L., Dong, Y., Wu, C., Li, Y., Guo, Y., Yang, B., Zong, X., Hamblin, M. R., Liu, T. C., & Zhang, Q. (2019) · Journal of Biophotonics · doi:10.1002/jbio.201800359 · Cited by 47
Andrew, R. J., De Rossi, P., Nguyen, P., Kowalski, H. R., Recupero, A. J., Guerbette, T., Krause, S. V., Rice, R. C., Laury-Kleintop, L., Wagner, S. L., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006379 · Cited by 55
Steele, J., Kim, S. H., Cirrito, J. R., Verges, D. K., Restivo, J. L., Westaway, D. A., Fraser, P., George‐Hyslop, P. S., Sano, M. C., Борисович, Б. И., et al. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-51 · Cited by 45
Alzheimer’s Disease and Protein Kinases
Engin, A. B., & Engin, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49844-3_11 · Cited by 43
The Inside-Out Amyloid Hypothesis and Synapse Pathology in Alzheimer's Disease
Gouras, G. K., Willén, K. I., & Faideau, M. (2013) · Neurodegenerative Diseases · doi:10.1159/000354776 · Cited by 42
Self-citationImpaired β-Amyloid Secretion in Alzheimer's Disease Pathogenesis
Tampellini, D., Rahman, N., Lin, M. T. S., Capetillo‐Zarate, E., & Gouras, G. K. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.2986-11.2011 · Cited by 41
Self-citationSoluble adenylyl cyclase is essential for proper lysosomal acidification
Rahman, N., Ramos-Espiritu, L. S., Milner, T. A., Buck, J., & Levin, L. R. (2016) · The Journal of General Physiology · doi:10.1085/jgp.201611606 · Cited by 44
Self-citationGouras, G. K., Willén, K., & Tampellini, D. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.06.004 · Cited by 39
Self-citationTriplett, J. C., Swomley, A. M., Cai, J., Klein, J. B., & Butterfield, D. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150417 · Cited by 40
Montarolo, F., Parolisi, R., Hoxha, E., Boda, E., & Tempia, F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069381 · Cited by 39
Li, X., Uemura, K., Hashimoto, T., Nasser-Ghodsi, N., Arimon, M., Lill, C. M., Palazzolo, I., Krainc, D., Hyman, B. T., & Berezovska, O. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.002 · Cited by 38
Rolland, M., Powell, R., Jacquier‐Sarlin, M. R., Boisseau, S., Reynaud-Dulaurier, R., Hernández, J. M., André, L., Borel, E., Buisson, A., & Lanté, F. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2501-19.2020 · Cited by 41
Mitochondrial dysfunction and cellular metabolic deficiency in Alzheimer’s disease
Gu, X., Huang, H., & Jiang, Z.-F. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1270-2 · Cited by 37
Pharmacokinetics and Pharmacodynamics of CHF5074 After Short-term Administration in Healthy Subjects
Imbimbo, B. P., Frigerio, E., Breda, M., Fiorentini, F., Fernández, M., Sivilia, S., Giardino, L., Calzà, L., Norris, D., Casula, D., et al. (2012) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3182622ace · Cited by 37
Martinsson, I., Quintino, L., Garcia, M. G., Konings, S. C., Torres-Garcia, L., Svanbergsson, A., Stange, O., England, R., Deierborg, T., Li, J., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.946297 · Cited by 35
Self-citationStein, E. S., Michaelson, D. M., & Chapman, J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07436.x · Cited by 34
Modulatory Activity of Soluble Beta Amyloid on HPA Axis Function in Rats
Morgese, M. G., Tucci, P., Colaianna, M., Zotti, M., Cuomo, V., Schiavone, S., & Trabace, L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990500 · Cited by 35
Şatır, T. M., Nazir, F. H., Vizlin‐Hodzic, D., Hardselius, E., Blennow, K., Wray, S., Zetterberg, H., Agholme, L., & Bergström, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-57516-7 · Cited by 32
Trans-Synaptic Spread of Amyloid-βin Alzheimer’s Disease: Paths toβ-Amyloidosis
Pignataro, A., & Middei, S. (2017) · Neural Plasticity · doi:10.1155/2017/5281829 · Cited by 34
García‐Viñuales, S., Sciacca, M. F. M., Lanza, V., Santoro, A. M., Grasso, G., Tundo, G. R., Sbardella, D., Coletta, M., Grasso, G., Rosa, C. L., et al. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105072 · Cited by 34
Gwon, Y., Kam, T., Kim, S.-H., Song, S., Park, H., Lim, B., Lee, H., Lee, W., Jo, D., & Jung, Y. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1996-17.2018 · Cited by 33
APP depletion alters selective pre- and post-synaptic proteins
Martinsson, I., Capetillo-Zarate, E., Faideau, M., Willén, K., Esteras, N., Frykman, S., Tjernberg, L. O., & Gouras, G. K. (2019) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2019.02.003 · Cited by 29
Self-citationTrafficking in neurons: Searching for new targets for Alzheimer's disease future therapies
Musardo, S., Saraceno, C., Pelucchi, S., & Marcello, E. E. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.07.019 · Cited by 29
Impaired brain plasticity as a potential therapeutic target for treatment and prevention of dementia
Rajji, T. K. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1550074 · Cited by 30
Willén, K. I., Sroka-Oleksiak, A., Takahashi, R. H., & Gouras, G. K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170262 · Cited by 28
Self-citationPKMζ, But Not PKCλ, Is Rapidly Synthesized and Degraded at the Neuronal Synapse
Palida, S. F., Butko, M. T., Ngo, J. T., Mackey, M. R., Gross, L. A., Ellisman, M. H., & Tsien, R. Y. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0004-15.2015 · Cited by 27
Akwa, Y., Malta, C. D., Zallo, F., Gondard, E., Lunati, A., Diaz-de-Grenu, L. Z., Zampelli, A., Boiret, A., Santamaria, S., Martinez-Preciado, M., et al. (2022) · Autophagy · doi:10.1080/15548627.2022.2095791 · Cited by 27
Self-citationSun, M., Asghar, S. Z., & Zhang, H. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.022 · Cited by 26
Intraneuronal Aβ Accumulation, Amyloid Plaques, and Synapse Pathology in Alzheimer’s Disease
Capetillo‐Zarate, E., Gracia, L., Tampellini, D., & Gouras, G. K. (2012) · Neurodegenerative Diseases · doi:10.1159/000334762 · Cited by 25
Self-citationDesmidt, T., Delrieu, J., Lebouvier, T., Robert, G., David, R., Balageas, A., Surget, A., Belzung, C., Arlicot, N., Ribeiro, M. J., et al. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.008 · Cited by 22
Muñoz, A. R., Pacheco, C. R., Aguayo, L. G., & Opazo, C. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.019 · Cited by 22
Irwin, J. A., Erişir, A., & Kwon, I. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160208142456 · Cited by 21
Bengtsson, S. K. S., Bäckström, T. C., Brinton, R. D., Irwin, R. W., Johansson, M., Sjöstedt, J., & Wang, M. D. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100206 · Cited by 22
Zhao, H., Huang, X., & Tong, Z. (2021) · ChemMedChem · doi:10.1002/cmdc.202100428 · Cited by 21
Phosphodiesterase Inhibition to Target the Synaptic Dysfunction in Alzheimer’s Disease
Bales, K. R., Plath, N., Svenstrup, N., & Menniti, F. S. (2010) · Topics in medicinal chemistry · doi:10.1007/7355_2010_8 · Cited by 22
Jia, K., Tian, J., Wang, T., Guo, L., Xuan, Z., Swerdlow, R. H., & Du, H. (2023) · JCI Insight · doi:10.1172/jci.insight.174290 · Cited by 20
Norvin, D., Kım, G., Baker‐Nigh, A., & Geula, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.011 · Cited by 19
Activity-independent release of the amyloid β-peptide from rat brain nerve terminals
Lundgren, J. L., Ahmed, S., Winblad, B. G., Gouras, G. K., Tjernberg, L. O., & Frykman, S. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.02.050 · Cited by 18
Self-citationFE65 proteins regulate NMDA receptor activation‐induced amyloid precursor protein processing
Suh, J., Lyckman, A. W., Wang, L., Eckman, E. A., & Guénette, S. Y. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07419.x · Cited by 18
Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
Gouras, G. K. (2013) · International Journal of Cell Biology · doi:10.1155/2013/141083 · Cited by 17
Self-citationApomorphine and Alzheimer Aβ: Roles for regulated α cleavage, autophagy, and antioxidation?
Steele, J., & Gandy, S. (2011) · Annals of Neurology · doi:10.1002/ana.22359 · Cited by 16
Nomura, S., Umeda, T., Tomiyama, T., & Mori, H. (2013) · Journal of Neuroscience Research · doi:10.1002/jnr.23278 · Cited by 13
The synaptomatrix: A solid though dynamic contact disconnecting transmissions from exocytotic events
Vautrin, J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.05.004 · Cited by 13
Metadata
- Authors
- Tampellini, D., Rahman, N., Gallo, E. F., Huang, Z., Dumont, M., Capetillo-Zarate, E., Ma, T., Zheng, R., Lu, B., Nanus, D. M., Lin, M. T., & Gouras, G. K.
- Affiliations
- Cornell University (US)
- Weill Cornell Medicine (US)
- Harvard University (US)
- Rockefeller University (US)
- Corresponding author
- Gouras, Gunnar K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2009-08-05
- Volume
- 29
- Issue
- 31
- Pages
- 9704-9713
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2763626
- OpenAlex
- W2094929105
- Cited by
- 127
- References
- 78
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 9 · 2020: 4 · 2019: 8 · 2018: 6 · 2017: 7 · 2016: 8 · 2015: 6 · 2014: 8 · 2013: 12 · 2012: 11
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Alzheimer's Association (AG09464)
- Weill Cornell Medical College
- National Institute on Aging (R01AG027140, AG09464, R01AG020729, K02AG028174, AG 20729, AG028174, AG027140, P01AG009464)
- National Institute of Neurological Disorders and Stroke (R01NS045677)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- synaptic activity, synaptotoxicity, neprilysin, Alzheimer's disease, synaptic plasticity, live-cell imaging
- MeSH terms
- Disks Large Homolog 4 Protein, Animals, Biological Transport, Active, Cells, Cultured, Extracellular Space, Hippocampus, Humans, Interneurons, Membrane Proteins, Mice, Transgenic, Synaptic Transmission, Neuronal Plasticity, Peptide Fragments, Receptors, Cell Surface, Synapses, Neprilysin, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Long-Term Potentiation, Intracellular Signaling Peptides and Proteins, Mice, Guanylate Kinases, Amyloid Precursor Protein Secretases, Protease Nexins, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
